the aid library

LIST OPTIONS

Filter

359

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO

District guidelines for yellow fever surveillance

World Health Organization WHO (1998) C_WHO

External Link

Disease Control Priorities, Third Edition : Volume 1. Essential Surgery

Debas, Haile T.; Donkor, Peter; Gawande, Atul; et al. (2015) CC

The volume presents data on the surgical burden of disease, disability, congenital anomalies, and trauma, along with health impact and economic analyses of procedures, platforms, and packages to improve care in settings with severe budget limitations. Essential Surgery identifies 44 surgical procedu... more

WHO aircraft disinsection methods and procedures

World Health Organization WHO (2021) C_WHO

Responding to communicable and noncommunicable diseases: progress report 2020-2022

World Health Organization WHO (2023) C_WHO

Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... more

Download (212)

View PDF (192)

Policy brief on tuberculosis-associated disability

World Health Organization WHO (2023) C_WHO

People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ... more

Download (173)

View PDF (224)

Lao People’s Democratic Republic-WHO Country Cooperation Strategy 2024–2028

World Health Organization WHO (2023) C_WHO

This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...2021–2030 to attain the Sustainable Development Goals (SDGs) by 2030. The Lao People’s Democratic Republic experienced substantial economic growth in the 30 years prior to the coronavirus disease (COVID-19) pandemic, contributing to reduced poverty and significant progress toward the SDGs. However, the COVID-19 pandemic brought this development to a halt. It was anticipated that the COVID-19 recovery and the tremendous population growth in recent years would provide opportunities for a shift toward more sustainable and inclusive development in the years ahead. In 2023, however, the contrary was the case. Rural residents, including many ethnic minorities, continued to face marginalization because of limited access to education, health care and economic opportunities. Despite the challenges of COVID-19 and other disease outbreaks, the country has made significant improvements in health. Nonetheless, progress has been uneven and not everyone has benefited from these achievements. In the mountainous region, many people lack access to quality health care because of the unequal distribution of well-trained health-care workers. Preventable deaths due to poor-quality health care for children and newborns, infants and mothers remain a concern, as do communicable diseases such as sexually transmitted infections and tuberculosis. The increasing burden of noncommunicable diseases and the health impact of worsening climate change further heighten the need for strengthened and resilient health systems, which are at risk due to an underfunded health sector and weak economy. This CCS aims to address remaining and future challenges as well as health needs while creating an impact that is sustainable. It identifies three strategic priorities and nine deliverables (Table 1) to support the attainment of the national vision of Health for all by all, as articulated in the 9th Health Sector Development Plan 2021–2025. It contributes to the country’s goals to achieve universal health coverage, graduate from least developed country status by 2026 and attain SDGs by 2030. more

Download (860)

View PDF (1893)

Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010

WHO (2010)

Guidelines for Workplace TB Control Activities

Benjamin O Alli [et al.] World Health Organisation, International Labour Organization (2003) C_WHO

This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contribution of employers and workers towards the control of TB. It covers all the practical steps involved in establishing TB control activities, including (for la... more

Guidelines for Implementing Collaborative TB and HIV Programme Activities

Stop TB Partnership. Working Group on TBHIV. Scientific Panel WHO (2003) C_WHO

The main aim of these guidelines is to enable the central units of national TB and HIV/AIDS programmes to support districts to plan, coordinate and implement collaborative TB/HIV activities. These guidelines reinforce current medical understanding, that highly active antiretroviral treatment (HAART)... more

Investigating cause of death during an outbreak of Ebola virus haemorrhagic fever: draft verbal autopsy instrument

World Health Organization (2003)

Download (751)

View PDF (1462)

Preventing violence and reducing its impact: how development agencies can help.

Alexander Butchart, David Brown, Andrew Wilson, and Christopher Mikton World Health Organization (2008)

Download (1040)

View PDF (1206)

Utilisation de la ventilation naturelle pour lutter contre les infections en milieu de soins

J. Atkinson, Y. Chartier, C.L.Pessoa-Silva, et.al Organisation Mondiale de la Santé (2009)

Download (804)

View PDF (1716)

Manual for the Development and Assessment of National Viral Hepatitis Plans

Joe Schofield, Sarah Hess, Bandana Malhotra et al. World Health Organization (WHO) (2015)

A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di... more

External Link

Guidelines for Prevention and Control of Chikungunya Fever

World Health Organization, Regional Office South-East Asia (2009)

Rapid ﬁeld entomological assessment during yellow fever outbreaks in Africa

World Health Organization WHO (2015) C_WHO

Methodological field approaches for scientists with a basic background in entomology to prepare and implement a yellow fever entomological assessment during outbreaks

Évaluation entomologique rapide sur le terrain pendant les épidémies de fièvre jaune en Afrique

Organisation Mondiale de la Santé OMS (2015) C_WHO

Risk assessment on yellow fever virus circulation in endemic countries

World Health Organization WHO (2014) C_WHO

Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo... more

External Link

Infection Control Assessment Tool for Primary Health Care Facilities

SIAPS USAID (2013) C1

Nosocomial or health-facility-acquired infections are a serious issue, representing one of the most significant causes of morbidity and mortality in healthcare systems and consuming many scarce resources, especially in developing countries. Although much has been done, particularly in the hospital s... more

Download (786)

View PDF (1155)

Key prevention and control interventions for reducing cancer burden in the WHO African Region

World Health Organization; Africa Region (2016) C_WHO

A handbook for leaders and managers

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings recommended

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended